Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Recruiting
Phase 2
Interventional Study
Acute Promyelocytic Leukemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- Up to 18
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 89 (estimated)
- Sponsor
- Associazione Italiana Ematologia Oncologia Pediatrica · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The trial is open to all patients with a diagnosis of acute promyelocytic leukemia (APL) who are PCR-positive for the PML-RARα transcript and less than 18 years of age.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Newly diagnosed APL confirmed by the presence of PML/RARα fusion gene
* Age \<18 years
* Written informed consent by parents or legal guardians
Exclusion Criteria:
* Patients with a clinical diagnosis of APL but subsequently found to lack PML/RARα rearrangement should be wit…
Contacts